Sleep apnoea is associated with significant daytime functioning impairment and marked
cardiovascular morbidities, leading to a significant increase in mortality. Sympathetic …

Background Central sleep apnea is associated with poor prognosis and death in patients
with heart failure. Adaptive servo-ventilation is a therapy that uses a noninvasive ventilator to …

The prevalence of sleep disordered breathing like obstructive sleep apnea (OSA) among
patients with atrial fibrillation (AF) is 40–50%. OSA reduces success rate of catheter based …

Rationale: Previous studies have demonstrated a high prevalence of sleep apnea (SA) in
patients with chronic heart failure (HF), which is associated with higher rates of morbidity …

Aims Central sleep apnoea/Cheyne–Stokes respiration (CSA/CSR) is a risk factor for
increased mortality and morbidity in heart failure (HF). Adaptive servo‐ventilation (ASV) is a …

Aims The SERVE‐HF trial investigated the impact of treating central sleep apnoea (CSA)
with adaptive servo‐ventilation (ASV) in patients with systolic heart failure. A preplanned …

Sleep-disordered breathing (SDB) is a common comorbidity in patients with heart failure
(HF). Prevalence of the most common subtypes of SDB, central sleep apnea (CSA) and …

Obstructive sleep apnoea, the most common form of sleep-disordered breathing, is highly
prevalent in patients with cardiovascular disease. The last 30 years has seen a plethora of …

Most patients with heart failure (HF) have sleep-disordered breathing (SDB), with central
(rather than obstructive) sleep apnea becoming the predominant form in patients with more …

Epilepsy is a group of neurological conditions in which there is a pathological and enduring
predisposition to generate recurrent seizures. Evidence over the last few decades suggests …